Oral Presentation

Clinical Practice (assessment, diagnosis, treatment, knowledge translation/EBP, implementation science, program development)

Adherence to OnabotulinumtoxinA Treatment in Post-Stroke and Multiple Sclerosis Patients with Spasticity from the ASPIRE Study

Presenting Author(s)

• 

  Alberto Esquenazi, MD

  Department Chair and Chief Medical Officer
  MossRehab Gait and Motion Analysis Laboratory
  Elkins Park, Pennsylvania

  Presentation Slides Presentation + Audio

Non-presenting Author(s)

• WF

  Wuwei Feng, MD, MS

  Division Chief, Stroke & Vascular Neurology
  Duke University School of Medicine
  Durham, North Carolina
• GW

  George F. Wittenberg, MD, PhD

  Professor of Neurology
  University of Maryland, University of Pittsburgh
  Pittsburgh, Pennsylvania
• PG

  Philippe Gallien, n/a

  Medical doctor
  Pole Saint Helier
  Rennes, Bretagne
• AB

  Alessio Baricich, n/a

  Assistant Professor
  Università dl Piemonte Orientale, Novara
  Novara, Piemonte
• KF

  Kristina M. Fanning, PhD

  Senior Project Director/ Statistician
  Vedanta Research
  Chapel Hill, North Carolina
• AZ

  Aleksej Zuzek, PhD

  Medical Director
  Allergan
  Irvine, California
• 

  Gerard E. Francisco, MD

  Professor and Chair
  University of Texas Health Science Center McGovern Medical School
  Houston, Texas
• DB

  Daniel S. Bandari, Bandari, MD

  Director
  MS Center of California & Research Group
  Newport Beach, California